Harry Rogoff

Harry Rogoff currently serves as the Director of Business Development - Therapeutics at Dana-Farber Cancer Institute, a role held since January 2023. Prior to this position, Harry was the Lead Accelerator & Chief Scientific Advisor at The Wistar Institute from October 2021 to January 2023. Between 2018 and September 2021, Harry held the title of Executive Director, Scientific Programs Evaluation at Sumitomo Dainippon Pharma Oncology. Harry also served as the Executive Director of Discovery Research at Boston Biomedical from 2007 to 2018 and was an Investigator at ArQule from 2004 to 2007. Harry earned a Doctor of Philosophy (PhD) from UMass Chan Medical School between 1997 and 2004, and obtained an undergraduate degree from Bates College from 1991 to 1995, with early education completed at Waynflete School from 1987 to 1991.